Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
|
Tolnaftate+chlorhexidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
|
Nystatin+chlorhexidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
|
Chlorhexidine hydrochloride and neomycin sulfate adverse reaction |
Causative agent (attribute) |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
2 |
Allergy to chlorhexidine hydrochloride and neomycin sulfate |
Causative agent (attribute) |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
|
Product containing chlorhexidine and tolnaftate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
|
Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
1 |
Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
2 |
Allergy to chlorhexidine hydrochloride and neomycin sulfate |
Causative agent (attribute) |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
2 |
Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
2 |
Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
2 |